Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 10, 2004, Pages 1428-1434

  Dunkelmann, Simone ^a   Wolf, Ricarda ^a   Koch, Annedore ^a   Kittner, Christian ^a   Groth, Peter ^a   Schuemichen, Carl ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Radiation induced Graves' disease; Radioiodine therapy; Thyroid autonomy; TRAb assay

Indexed keywords

IODINE 131; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ANIMAL CELL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ECHOGRAPHY; ENDOCRINE OPHTHALMOPATHY; EPITHELIUM CELL; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RADIATION DOSE; RADIATION INJURY; RADIOISOTOPE THERAPY; SWINE; THYROID FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; CAUSALITY; COMORBIDITY; FEMALE; GERMANY; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IMMUNOASSAY; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIATION INJURIES; RECEPTORS, THYROTROPIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 5444234156     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1519-8     Document Type: Article

References (31)

1. Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. J Clin Endocrinol 1994, 40.803-806.
2. 131I treatment in patients with non toxic-goiter J Clin Endocrinol Metab 1997; 82:2926-2930
3. Hirsch C, Spyra J, Langhammer R, Laubenbacher C, Senekowitsch-Schmidtke R, Schwaiger M Zum Auftreten einer Immunhyperthyreose nach Radioiodtherapie von Schilddrüsenautonomien. Med Klin 1997; 92:130-137.
4. Dunkelmann S, Rudolph F, Prillwitz A, Groth P, Schuemichen C. Paradoxical effects of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy. Nuklearmedizin 1998; 37:17-22.
5. 131I therapy Thyroid 1999; 9.477-481
6. 131I therapy for toxic nodule. Thyroid 2001; 10:91-92
7. Wallaschofski H, Orda C, Georgi P, Paschke R Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Horm Metab Res 2001; 33:504-507.
8. Wallaschofski H, Muller D, Georgi P, Paschke R. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radiolodine treatment Horm Metab Res 2002; 34:36-39.
9. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglohmer W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease J Clin Endocrinol Metab 1999; 84:90-97
10. Pedersen I, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism in Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf) 2001, 55:381-390.
11. Meller J, Jauho A, Hüfner M, Gratz S, Becker W. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 2000; 10:1073-1079.
12. Dunkelmann S, Endlicher D, Prillwitz A, Rudolph F, Groth P, Schuemichen C Results of TcTUs-optimized radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Nuklearmedizin 1999, 38:131-139.
13. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC Volumetry of the lobe of the thyroid gland by means of realtime sonography. Dtsch Med Wochenschr 1981; 106:1338-1340.
14. DeGroot LJ Radioiodine and immune system Thyroid 1997; 7:259-264.
15. Regalbuto C, Salamone S, Scollo C, Vignen R, Pezzino V Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma. J Endocrinol Invest 1999; 22-147-150.
16. Davies TF. The thyroid immunology of the postpartum period Thyroid 1999; 9 675-684.
17. Ando T, Davies TF. Clinical review 160: postpartum autoimmune thyroid disease: the potential role of fetal microchimerism. J Clin Endocrinol Metab 2003; 88:2965-2971.
18. Pedersen OM, Bennedbaek FN, Hoir-Madsen M, Jacobsen BB, Hegedus L. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 2000; 10.251-259.
19. Hansen D, Bennedbaek FN, Hoir-Madson M, Hegedus L, Jacobsen BB. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. Eur J Endocrinol 2003; 148:245-251.
20. Weetmann AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; 148:1-9
21. Sugenoya A, Kobayashi S, Kasuga Y, Masuda H, Fujimori M, Komatsu M, Takahashi S, Yokoyama S, Shimizu T, Yamada T. Evidence of intrathyroidal accumulation of TSH receptor antibody in Graves' disease. Acta Endocrinol 1992; 126:416-418.
22. Sakaguchi S, Ermak TH, Toda M, Berg LJ, Ho W, Fazekas de St Groth B, Perterson PA, Sakaguchi N, Davis MM Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression J Immunol 1994; 152:1471-1484
23. Monzam F, Del Guerra P, Caraccio N, Casolaro A, Lippolis PV, Goletti O. Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma. J Endocrinol Invest 1997; 20:294-298.
24. Verde G Graves' disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma. J Endocrinol Invest 1998, 21:334-335
25. Orsolon P, Lupi A, De Antoni Migliorati G, Vianello Dri A. Appearance of Graves' disease following regression of autonomously functioning thyroid nodules. Two case reports. Minerva Endocrinol 1998; 23 53-56
26. Wallfish PG, Caplan D, Rosen IB. Postparathyroidectomy transient thyrotoxicosis. J Clin Endocrinol Metab 1992; 75:224-227.
27. Freeman JS, Ertel NH, McA'Nulty JA, Khan MY. Graves' disease following resection of an autonomous solitary thyroid adenoma J Med Soc N Y 1983; 80:444-446
28. Bartalena L, Bogazzi F, Pecori F, Martino E Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature. Thyroid 1996; 6:345-348
29. Bergoglio LM, Vilchez PE, Fatemi S, Spencer CA. TPOAb assay limitations may be responsible for the skew in the TSH upper reference limit. Proceedings of the Latin American Thyroid Society, Cordoba, Argentina 2003; A:123.
30. Hollowell JG, Staehling NW, Hannon WH, Flanders WD, Gunter EW, Spencer CA, Bravermann LE. Serum thyrotropin, thyroxine and thyroid antibodies in the United States population (1988-1994): NHANES II. J Clin Endocrinol Metab 2002; 87:489-499.
31. Pedersen IB, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 2002; 58:36-42.